Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) Return on Equity (2017 - 2025)

Historic Return on Equity for Selectis Health (GBCS) over the last 13 years, with Q3 2025 value amounting to 0.43%.

  • Selectis Health's Return on Equity fell 15500.0% to 0.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.43%, marking a year-over-year decrease of 15500.0%. This contributed to the annual value of 1.14% for FY2024, which is 99300.0% down from last year.
  • Selectis Health's Return on Equity amounted to 0.43% in Q3 2025, which was down 15500.0% from 0.6% recorded in Q2 2025.
  • Selectis Health's 5-year Return on Equity high stood at 9.74% for Q4 2023, and its period low was 5.47% during Q3 2023.
  • Moreover, its 5-year median value for Return on Equity was 0.12% (2022), whereas its average is 0.35%.
  • As far as peak fluctuations go, Selectis Health's Return on Equity skyrocketed by 107300bps in 2023, and later crashed by -88000bps in 2024.
  • Quarter analysis of 5 years shows Selectis Health's Return on Equity stood at 0.99% in 2021, then increased by 0bps to 0.99% in 2022, then surged by 1082bps to 9.74% in 2023, then crashed by -90bps to 0.93% in 2024, then tumbled by -54bps to 0.43% in 2025.
  • Its last three reported values are 0.43% in Q3 2025, 0.6% for Q2 2025, and 0.77% during Q1 2025.